New approaches aim to extend treatment durability and improve long-term vision outcomes in wet AMD. 
Scientific American Custom Media recently sat down with Dr. Nadia Waheed, Ocular Therapeutix’s chief medical officer, to discuss the real-world burden behind the standard of care and how emerging approaches, including sustained-delivery therapies under investigation, aim to reduce it. 
This podcast was produced for Ocular Therapeutix by Scientific American Custom Media, a division separate from the magazine’s board of editors.
Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Reducing Treatment Burden While Preserving Sight [Sponsored]

Science Quickly

AI Chapters

AI Insights

Reviews